Compare Manchester United PLC (MANU) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manchester United PLC vs Neurocrine Biosciences Inc — how do they compare? Manchester United PLC trades at $22.23 (market cap $3.80B), while Neurocrine Biosciences Inc trades at $151.32 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.3× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| MANU | NBIX | |
|---|---|---|
Market Cap | $3.80B | $16.46B |
Sector | Media | Health |
52-Week High | $23.53 | $185.50 |
52-Week Low | $15.10 | $123.10 |
Enterprise Value | $4.74B | $16.48B |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
